AI Market Mood: Stock Dashboard
ZBIO
Fundamental
Company: Zenas Biopharma Inc
Sector: Healthcare
Industry: Biotechnology
Country: USA
Exchange: NASD
Index: RUT
P/E: -
EPS (ttm): -8.44
Insider Own: 56.05%
Shs Outstand: 54.49M
Perf Week: 22.35%
Market Cap: 1.28B
Forward P/E: -
EPS next Y: -4.73
Insider Trans: 4.78%
Shs Float: 25.21M
Perf Month: -11.80%
Enterprise Value: 1.01B
PEG: -
EPS next Q: -1.47
Inst Own: 43.16%
Short Float: 30.58%
Perf Quarter: -35.42%
Income: -377.74M
P/S: 127.80
EPS this Y: 42.83%
Inst Trans: 9.65%
Short Ratio: 7.43
Perf Half Y: 6.35%
Sales: 10.00M
P/B: 5.01
EPS next Y Percentage: 1.88%
ROA: -100.25%
Short Interest: 7.71M
Perf YTD: -38.64%
Book/sh: 4.44
P/C: 3.72
EPS next 5Y: 23.12%
ROE: -136.22%
52W High: 44.60 -50.04%
Perf Year: 188.98%
Cash/sh: 5.98
P/FCF: -
EPS past 3/5Y: -39.47% -
ROIC: -117.68%
52W Low: 6.11 264.65%
Perf 3Y: -
Dividend Est.: -
EV/EBITDA: -
Sales past 3/5Y: - -
Gross Margin: 99.44%
Volatility W: 8.47%
Volatility M: 8.10%
Perf 5Y: -
Dividend TTM: -
EV/Sales: 101.48
EPS Y/Y TTM: -116.54%
Oper. Margin: -2113.85%
ATR (14): 1.91
Perf 10Y: -
Dividend Ex-Date: -
Quick Ratio: 5.61
Sales Y/Y TTM: 100.00%
Profit Margin: -3777.37%
RSI (14): 49.36
Recom: 1.25
Dividend Gr. 3/5Y: - -
Current Ratio: 5.61
EPS Q/Q: -310.86%
SMA20: -0.42%
Beta: -0.51
Target Price: 42.00
Payout: -
Debt/Eq: 0.33
Sales Q/Q: -100.00%
SMA50: -3.40%
Rel Volume: 0.53
Prev Close: 21.46
Employees: 167
LT Debt/Eq: 0.33
Earnings: Mar 16 BMO
SMA200: -4.33%
Avg Volume: 1.04M
Price: 22.28
IPO: Sep 13, 2024
Option/Short: Yes / Yes
EPS/Sales Surpr.: -353.37% -100.00%
Trades:
Volume: 377,640
Change: 3.82%
Technical:
Latest News:
Bristol-Myers Squibb-backed Zenas BioPharma seeks up to $689.7 million valuation in US IPO somewhat bullish
ZBIO
Summary: Zenas BioPharma aims for a valuation of up to $689.7 million in its U.S. IPO, backed by Bristol-Myers Squibb and targeting to raise $211.7 million by offering 11.76 million shares.
Full article2024-09-06T12:28:43Z